Antibodies & Hybridomas — page 1 of 2
Antibodies & Hybridomas
Page 1 of 2
| Specificity | Clone | Host Species | Reactive Species | Format | Size | Reviews | Supplier | |
|---|---|---|---|---|---|---|---|---|
| SARS-CoV-2 Variants (Omicron) S1 | monoclonal | Recombinant Rabbit | SARS-CoV, SARS-CoV-2 variants of Omicron (B.1.1.529) and Delta (B.1.617.2). | unconjugated | n/a | n/a |
 CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Variants (Omicron) S RBD | monoclonal | Recombinant Mouse | SARS-CoV-2, SARS-CoV-2 variants of Omicron (B.1.1.529) and Delta (B.1.617.2). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Variants (Omicron) S RBD | monoclonal | Recombinant Rabbit | HCoV, SARS-CoV, SARS-CoV-2 variants of Omicron (B.1.1.529) and Delta (B.1.617.2). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Variants (Omicron) S RBD | monoclonal | Recombinant Human | SARS-CoV, SARS-CoV-2 variants of Omicron (B.1.1.529) and Delta (B.1.617.2). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Variants (Omicron) S RBD | monoclonal | Recombinant Human | SARS-CoV, SARS-CoV-2 variants of Omicron (B.1.1.529) and Delta (B.1.617.2). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Variants (Omicron) S RBD | monoclonal | Recombinant Human | SARS-CoV, SARS-CoV-2 variants of Omicron (B.1.1.529) and Delta (B.1.617.2). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Variants (Omicron) S RBD | monoclonal | Recombinant Human | SARS-CoV, SARS-CoV-2 variants of Omicron (B.1.1.529) and Delta (B.1.617.2). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Variants (Omicron) S RBD | monoclonal | Recombinant Mouse | SARS-CoV, SARS-CoV-2 variants of Omicron (B.1.1.529) and Delta (B.1.617.2). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Variants (Omicron) S RBD | monoclonal | Recombinant Mouse | SARS-CoV, SARS-CoV-2 variants of Omicron (B.1.1.529) and Delta (B.1.617.2). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Variants (Omicron) S RBD | monoclonal | Recombinant Rabbit | SARS-CoV, SARS-CoV-2 variants of Omicron (B.1.1.529) and Delta (B.1.617.2). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Variants (Omicron) S RBD | monoclonal | Recombinant Rabbit | SARS-CoV, SARS-CoV-2 variants of Omicron (B.1.1.529) and Delta (B.1.617.2). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV Spike (SΔ3) | 7G12 | Mouse | sars coronavirus | Protein G purified | 100 µl | n/a |
 GENETEX INC. |
More Info |
| SARS-CoV-2 (Delta B.1.617.2 Variant) S RBD | monoclonal | Recombinant Human | SARS-CoV-2 (Delta B.1.617.2 Variant) | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV/SARS-CoV-2 Variant (Beta, Delta, Omicron (BA.5)) Spike Trimer | P1A7 | Recombinant Camelid | n/a | unconjugated | 0.1 mg | n/a |
 BIORBYT LTD. |
More Info |
| SARS-CoV/SARS-CoV-2 Variant (Delta, Omicron (BA.1/BA.5)) Spike Trimer | T3P1C4 | Recombinant Camelid | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
| SARS-CoV/SARS-CoV-2 Variant (Delta, Omicron (BA.1/BA.5)) Spike Trimer | T3P1D2 | Recombinant Camelid | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
| SARS-CoV/SARS-CoV-2 Variant (Delta, Omicron (BA.1/BA.5)) Spike Trimer | T3P1E1 | Recombinant Camelid | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
| SARS-CoV/SARS-CoV-2 Variant (Delta, Omicron (BA.1/BA.5)) Spike Trimer | T3P2D11 | Recombinant Camelid | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
| SARS-CoV/SARS-CoV-2 Variant (Delta, Omicron (BA.1/BA.5)) Spike Trimer | T3P3F4 | Recombinant Camelid | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 (COVID-19) Spike P681R | 5H4C5 | Mouse | n/a | unconjugated | 0.1 mg, 0.02 mg | n/a |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 (COVID-19) Spike P681R | 7E3C5 | Mouse | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
| SARS-CoV/SARS-CoV-2 Spike Glycoprotein RBD | D002 | Chimeric | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617.2); | unconjugated | 100 µL | n/a |
 CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Spike Glycoprotein RBD | D002 | Chimeric | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617.2); | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Spike Glycoprotein RBD | D003 | Chimeric | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (BA.1.1), SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron (BA.2.12.1), SARS-CoV-2 Omicron (BA.2.75.2), SARS-CoV-2 (BA.2.3.20), SARS-CoV-2 (BA.2.75), SARS-CoV-2 Omicron (BA.4), SARS-CoV-2 Omicron (BA.4.6 / BF.7), SARS-CoV-2 Omicron (BA.5), SARS-CoV-2 Omicron (BQ.1.1), SARS-CoV-2 Omicron (XBB) | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Spike Glycoprotein RBD | D003 | Chimeric | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (BA.1.1), SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron (BA.2.12.1), SARS-CoV-2 Omicron (BA.2.75.2), SARS-CoV-2 (BA.2.3.20), SARS-CoV-2 (BA.2.75), SARS-CoV-2 Omicron (BA.4), SARS-CoV-2 Omicron (BA.4.6 / BF.7), SARS-CoV-2 Omicron (BA.5), SARS-CoV-2 Omicron (BQ.1.1), SARS-CoV-2 Omicron (XBB) | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Spike Glycoprotein RBD | D004 | Chimeric | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.1.1), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron (BA.2.12.1), SARS-CoV-2 (BA.2.3.20), SARS-CoV-2 (BA.2.75), SARS-CoV-2 Omicron (BA.2.75.2), SARS-CoV-2 Omicron (BA.4), SARS-CoV-2 Omicron (BA.4.6 / BF.7), SARS-CoV-2 Omicron (BA.5), SARS-CoV-2 Omicron (BQ.1.1), SARS-CoV-2 Omicron (XBB) | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Spike Glycoprotein RBD | D004 | Chimeric | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.1.1), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron (BA.2.12.1), SARS-CoV-2 (BA.2.3.20), SARS-CoV-2 (BA.2.75), SARS-CoV-2 Omicron (BA.2.75.2), SARS-CoV-2 Omicron (BA.4), SARS-CoV-2 Omicron (BA.4.6 / BF.7), SARS-CoV-2 Omicron (BA.5), SARS-CoV-2 Omicron (BQ.1.1), SARS-CoV-2 Omicron (XBB) | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Spike Glycoprotein RBD | D006 | Chimeric | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (BA.1.1), SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron (BA.2.12.1), SARS-CoV-2 Omicron (BA.2.75.2), SARS-CoV-2 (BA.2.3.20), SARS-CoV-2 (BA.2.75), SARS-CoV-2 Omicron (BA.4), SARS-CoV-2 Omicron (BA.4.6 / BF.7), SARS-CoV-2 Omicron (BA.5), SARS-CoV-2 Omicron (BQ.1.1), SARS-CoV-2 Omicron (XBB) | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Spike Glycoprotein RBD | D006 | Chimeric | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (BA.1.1), SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron (BA.2.12.1), SARS-CoV-2 Omicron (BA.2.75.2), SARS-CoV-2 (BA.2.3.20), SARS-CoV-2 (BA.2.75), SARS-CoV-2 Omicron (BA.4), SARS-CoV-2 Omicron (BA.4.6 / BF.7), SARS-CoV-2 Omicron (BA.5), SARS-CoV-2 Omicron (BQ.1.1), SARS-CoV-2 Omicron (XBB) | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Spike Glycoprotein RBD | D001 | Chimeric | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Omicron (B.1.1.529); | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Spike Glycoprotein RBD | D001 | Chimeric | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Omicron (B.1.1.529); | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Spike Glycoprotein RBD | D005 | Chimeric | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (BA.1.1), SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron (BA.2.12.1), SARS-CoV-2 Omicron (BA.2.75.2), SARS-CoV-2 (BA.2.3.20), SARS-CoV-2 (BA.2.75), SARS-CoV-2 Omicron (BA.4), SARS-CoV-2 Omicron (BA.4.6 / BF.7), SARS-CoV-2 Omicron (BA.5), SARS-CoV-2 Omicron (BQ.1.1), SARS-CoV-2 Omicron (XBB) | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Spike Glycoprotein RBD | D005 | Chimeric | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (BA.1.1), SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron (BA.2.12.1), SARS-CoV-2 Omicron (BA.2.75.2), SARS-CoV-2 (BA.2.3.20), SARS-CoV-2 (BA.2.75), SARS-CoV-2 Omicron (BA.4), SARS-CoV-2 Omicron (BA.4.6 / BF.7), SARS-CoV-2 Omicron (BA.5), SARS-CoV-2 Omicron (BQ.1.1), SARS-CoV-2 Omicron (XBB) | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein RBD (Delta B.1 | monoclonal | Recombinant Human | n/a | Protein A purified | 50 µg, 100 µg, | n/a |
 ABBEXA LTD |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 040 | Rabbit | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron XE (BA.1 x BA.2), SARS-CoV-2 Omicron (BA.4), SARS-CoV-2 Delta (B.1.617.2); | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 040 | Rabbit | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron XE (BA.1 x BA.2), SARS-CoV-2 Omicron (BA.4), SARS-CoV-2 Delta (B.1.617.2); | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV-2 Variants (Omicron) NP | monoclonal | Recombinant Mouse | SARS-CoV-2, SARS-CoV-2 variants of Omicron (B.1.1.529) and Delta (B.1.617.2). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Variants (Omicron) NP | monoclonal | Recombinant Rabbit | SARS-CoV-2, SARS-CoV-2 variants of Omicron (B.1.1.529) and Delta (B.1.617.2). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Variants (Omicron) NP | monoclonal | Recombinant Rabbit | SARS-CoV-2, SARS-CoV-2 variants of Omicron (B.1.1.529) and Delta (B.1.617.2). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Variants (Omicron) NP | monoclonal | Recombinant Rabbit | SARS-CoV-2, SARS-CoV-2 variants of Omicron (B.1.1.529) and Delta (B.1.617.2). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Variants (Omicron) S | monoclonal | Recombinant Human | MERS, SARS-CoV, SARS-CoV-2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 (COVID-19) Spike 156-157EFdel (Delta Variant) | polyclonal | Rabbit | n/a | unconjugated | 0.1 mg, 0.02 mg | n/a |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 (COVID-19) Spike L452R (Delta Variant) | polyclonal | Rabbit | n/a | unconjugated | 0.1 mg, 0.02 mg | n/a |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 (COVID-19) Spike G142D Δ143-145VYY (Omicron) | polyclonal | Rabbit | n/a | unconjugated | 0.1 mg, 0.02 mg | n/a |
BIORBYT LTD. |
More Info |
| SARS-CoV / SARS-CoV-2 (COVID-19) spike | 1A9 | Mouse | sars coronavirus, sars coronavirus 2 | Protein G purified | 100 µl | n/a |
GENETEX INC. |
More Info |
| SARS-CoV-2 Spike Glycoprotein Neutralizing | 001 | Rabbit | SARS-CoV-2, SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 (BA.2.75), SARS-CoV-2 (BA.2.3.20); | unconjugated | 100 µg | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV-2 Spike Glycoprotein Neutralizing | 57 | Mouse | SARS-CoV-2, SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (BA.1.1); | unconjugated | 100 µg | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 004 | Rabbit | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617), SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron XE (BA.1 x BA.2), SARS-CoV-2 Omicron (BA.4); | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 004 | Rabbit | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617), SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron XE (BA.1 x BA.2), SARS-CoV-2 Omicron (BA.4); | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 08 | Mouse | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617), SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron XE (BA.1 x BA.2), SARS-CoV-2 Omicron (BA.4); | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 08 | Mouse | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617), SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron XE (BA.1 x BA.2), SARS-CoV-2 Omicron (BA.4); | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 019 | Rabbit | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron XE (BA.1 x BA.2), SARS-CoV-2 Omicron (BA.4), SARS-CoV-2 Delta (B.1.617.2); | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 019 | Rabbit | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron XE (BA.1 x BA.2), SARS-CoV-2 Omicron (BA.4), SARS-CoV-2 Delta (B.1.617.2); | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV-2 Variants (Omicron) NP | monoclonal | Recombinant Rabbit | SARS Coronavirus, SARS-CoV-2 Variants of Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Eta(B.1.525), Delta (B.1.617.2) and Omicron (B.1.1.529). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Variants (Omicron) S RBD | monoclonal | Recombinant Human | SARS-CoV-2 variants of Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2) and Omicron (B.1.1.529). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Variants (Omicron) S RBD | monoclonal | Recombinant Human | SARS-CoV-2, SARS-CoV-2 Variants of Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2) and Omicron (B.1.1.529). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Spike Glycoprotein S1 Subunit Neutralizing | 43 | Mouse | SARS-CoV-2, SARS-CoV-2 Delta (B.1.617.2); | unconjugated | 100 µg | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV-2 Variants (Omicron) NP | monoclonal | Recombinant Rabbit | SARS Coronavirus, SARS-CoV-2 Variants of Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Eta(B.1.525), Delta (B.1.617.2) and Omicron (B.1.1.529). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Variants (Omicron) NP | monoclonal | Recombinant Mouse | SARS-CoV, SARS-CoV-2 Variants of Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Eta(B.1.525), Delta (B.1.617.2) and Omicron (B.1.1.529). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Variants (Omicron) NP | monoclonal | Recombinant Mouse | SARS-CoV, SARS-CoV-2 Variants of Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Eta(B.1.525), Delta (B.1.617.2) and Omicron (B.1.1.529). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Variants (Omicron) NP | monoclonal | Recombinant Mouse | SARS-CoV, SARS-CoV-2 Variants of Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Eta(B.1.525), Delta (B.1.617.2) and Omicron (B.1.1.529). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Variants (Omicron) NP | monoclonal | Recombinant Rabbit | SARS-CoV, SARS-CoV-2 Variants of Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Eta(B.1.525), Delta (B.1.617.2) and Omicron (B.1.1.529). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Spike Glycoprotein S1 Subunit | 007 | Rabbit | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Delta (B.1.617.2); | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV-2 Spike Glycoprotein S1 Subunit | 007 | Rabbit | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Delta (B.1.617.2); | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV-2 Spike Glycoprotein S1 Subunit | 42 | Mouse | SARS-CoV-2, SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (BA.2); | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV-2 Spike Glycoprotein S2 Subunit Extracellular Domain | D001 | Chimeric | SARS-CoV-2; | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV-2 Spike RBD (Delta Specific) | AM110 | Chimeric | n/a | purified | 100ug | n/a |
 ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Spike RBD (Delta Specific) | AM110 | Chimeric | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Spike RBD (Delta Specific) | AS110 | Mouse | n/a | purified | 100ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Spike RBD (Delta Specific) | AS110 | Mouse | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Delta Spike RBD and ECD | monoclonal | Chimera | SARS-CoV-2 | Protein A purified | 100µg | n/a |
 SINO BIOLOGICAL, INC. |
More Info |
| SARS-CoV-2 Spike RBD | AM130 | Chimeric | n/a | purified | 100ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Spike RBD | AM130 | Chimeric | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Variants (Omicron) S RBD | monoclonal | Recombinant | SARS Coronavirus, SARS-CoV-2 Variants of Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2) and Omicron (B.1.1.529). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Variants (Omicron) S RBD | monoclonal | Recombinant Mouse | SARS Coronavirus-2, SARS-CoV-2 Variants of Alpha (B.1.1.7), Beta (B.1.351), Kappa (B.1.617.1), Delta (B.1.617.2) and Omicron (B.1.1.529). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Spike RBD Neutralizing | AM122 | Chimeric | n/a | biotin conjugate | 25ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Spike RBD Neutralizing | AM122 | Chimeric | n/a | biotin conjugate | 200ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Spike RBD Neutralizing | AM122 | Chimeric | n/a | phycoerythrin (PE) conjugate | 25 tests | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Spike RBD Neutralizing | AM122 | Chimeric | n/a | phycoerythrin (PE) conjugate | 200 tests | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Spike RBD Neutralizing | AM122 | Chimeric | n/a | purified | 100ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Spike RBD Neutralizing | AM122 | Chimeric | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Spike RBD Neutralizing | AM122 | Chimeric | n/a | purified | 10mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Spike RBD Neutralizing | AM122 | Chimeric | n/a | purified | 100mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Spike RBD Neutralizing | AM122 | Chimeric | n/a | purified | 100ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Spike RBD Neutralizing | AM122 | Chimeric | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Omicron XBB.1 Spike | monoclonal | Chimera | SARS-CoV-2 | Protein A purified | 100µg | n/a |
SINO BIOLOGICAL, INC. |
More Info |
| SARS-CoV-2 Spike RBD Broadly Neutralizing | AM359b | Recombinant Human | n/a | purified | 100ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Spike RBD Broadly Neutralizing | AM359b | Recombinant Human | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Spike RBD Broadly Neutralizing | AM359b | Recombinant Human | n/a | purified | 100ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Spike RBD Broadly Neutralizing | AM359b | Recombinant Human | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Spike RBD Broadly Neutralizing | AM359b | Recombinant Human | n/a | purified | 100ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Spike RBD Broadly Neutralizing | AM359b | Recombinant Human | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Spike RBD Broadly Neutralizing | AM359b | Recombinant Human | n/a | purified | 100ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Spike RBD Broadly Neutralizing | AM359b | Recombinant Human | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 (COVID-19) Spike RBD Omicron | HL1866 | Rabbit | sars coronavirus 2 | Protein A purified | 100 µl | n/a |
GENETEX INC. |
More Info |
| SARS-CoV-2 (COVID-19) Spike RBD Omicron | HL1867 | Rabbit | sars coronavirus 2 | Protein A purified | 100 µl | n/a |
GENETEX INC. |
More Info |
| SARS-CoV-2 Neutralizing for Wild Type and Variants | monoclonal | Mouse | n/a | purified | n/a | n/a |
 MOLECULAR DEPOT |
More Info |
| SARS-CoV-2 Alpha Spike RBD and ECD | monoclonal | Chimera | SARS-CoV-2 | Protein A purified | 100µg | n/a |
SINO BIOLOGICAL, INC. |
More Info |
| SARS-CoV-2 Spike RBD (Beta & Gamma Specific) | AS106 | Mouse | n/a | purified | 100ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Spike RBD (Beta & Gamma Specific) | AS106 | Mouse | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |